Within-Trial Cost-Effectiveness of an Adherence-Enhancing Educational Intervention for Glaucoma
Copyright © 2022 Elsevier Inc. All rights reserved..
PURPOSE: To assess the within-trial cost-effectiveness of a behavioral intervention to improve glaucoma medication adherence.
DESIGN: Prospective cost-effectiveness analysis of randomized, controlled trial data.
METHODS: The study setting was a Veterans Affairs (VA) eye clinic. The patient population comprised veterans with medically treated glaucoma and self-reported poor adherence. Participants were randomized to a personalized educational session with a reminder bottle to promote medication adherence or to a control session on general eye health. Costs were assessed from the perspective of the VA payor at 6 months using the VA Managerial Cost Accounting System. Probabilistic sensitivity analyses were conducted using bootstrapped samples. The main outcome measures were the proportion of participants attaining ≥80% adherence as measured by electronic monitor, total intervention and medical resource costs, and incremental cost-effectiveness ratios comparing intervention to control at 6 months.
RESULTS: Of 200 randomized participants, 95 of 100 assigned to the intervention and 97 of 100 assigned to the control had adherence outcomes at 6 months, and the proportion of adherent patients was higher in the intervention group compared to control (0.78 vs 0.40, P < .0001). All participants had costs at 6 months. The total cost at 6 months was $1,149,600 in the intervention group (n = 100) compared to $1,298,700 in the control group (n = 100). Thus, in a hypothetical cohort of 100 patients, the intervention was associated with cost savings (-$149,100) and resulted in 38 additional patients achieving medication adherence.
CONCLUSIONS: An adherence-enhancing behavioral intervention was effective and cost saving at 6 months.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:244 |
---|---|
Enthalten in: |
American journal of ophthalmology - 244(2022) vom: 25. Dez., Seite 216-227 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Williams, Andrew M [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 30.11.2022 Date Revised 02.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ajo.2022.08.011 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM345205332 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM345205332 | ||
003 | DE-627 | ||
005 | 20231226024533.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ajo.2022.08.011 |2 doi | |
028 | 5 | 2 | |a pubmed24n1150.xml |
035 | |a (DE-627)NLM345205332 | ||
035 | |a (NLM)36002073 | ||
035 | |a (PII)S0002-9394(22)00311-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Williams, Andrew M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Within-Trial Cost-Effectiveness of an Adherence-Enhancing Educational Intervention for Glaucoma |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 30.11.2022 | ||
500 | |a Date Revised 02.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Elsevier Inc. All rights reserved. | ||
520 | |a PURPOSE: To assess the within-trial cost-effectiveness of a behavioral intervention to improve glaucoma medication adherence | ||
520 | |a DESIGN: Prospective cost-effectiveness analysis of randomized, controlled trial data | ||
520 | |a METHODS: The study setting was a Veterans Affairs (VA) eye clinic. The patient population comprised veterans with medically treated glaucoma and self-reported poor adherence. Participants were randomized to a personalized educational session with a reminder bottle to promote medication adherence or to a control session on general eye health. Costs were assessed from the perspective of the VA payor at 6 months using the VA Managerial Cost Accounting System. Probabilistic sensitivity analyses were conducted using bootstrapped samples. The main outcome measures were the proportion of participants attaining ≥80% adherence as measured by electronic monitor, total intervention and medical resource costs, and incremental cost-effectiveness ratios comparing intervention to control at 6 months | ||
520 | |a RESULTS: Of 200 randomized participants, 95 of 100 assigned to the intervention and 97 of 100 assigned to the control had adherence outcomes at 6 months, and the proportion of adherent patients was higher in the intervention group compared to control (0.78 vs 0.40, P < .0001). All participants had costs at 6 months. The total cost at 6 months was $1,149,600 in the intervention group (n = 100) compared to $1,298,700 in the control group (n = 100). Thus, in a hypothetical cohort of 100 patients, the intervention was associated with cost savings (-$149,100) and resulted in 38 additional patients achieving medication adherence | ||
520 | |a CONCLUSIONS: An adherence-enhancing behavioral intervention was effective and cost saving at 6 months | ||
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
700 | 1 | |a Theophanous, Christos |e verfasserin |4 aut | |
700 | 1 | |a Muir, Kelly W |e verfasserin |4 aut | |
700 | 1 | |a Rosdahl, Jullia A |e verfasserin |4 aut | |
700 | 1 | |a Woolson, Sandra |e verfasserin |4 aut | |
700 | 1 | |a Olsen, Maren |e verfasserin |4 aut | |
700 | 1 | |a Bosworth, Hayden B |e verfasserin |4 aut | |
700 | 1 | |a Hung, Anna |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t American journal of ophthalmology |d 1945 |g 244(2022) vom: 25. Dez., Seite 216-227 |w (DE-627)NLM000124443 |x 1879-1891 |7 nnns |
773 | 1 | 8 | |g volume:244 |g year:2022 |g day:25 |g month:12 |g pages:216-227 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajo.2022.08.011 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 244 |j 2022 |b 25 |c 12 |h 216-227 |